Product
Recombinant granulocyte-colony stimulating factor
1 clinical trial
1 indication
Indication
Stevens-Johnson SyndromeClinical trial
Evaluation of G-CSF as a Treatment of Toxic Epidermal NecrolysisStatus: Completed, Estimated PCD: 2023-03-07
1 clinical trial
1 indication